These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1307535

  • 1. Dapsone in cutaneous lesions of SLE: an open study.
    Singh YN, Adya CM, Verma KK, Kumar A, Malaviya AN.
    J Assoc Physicians India; 1992 Nov; 40(11):735-6. PubMed ID: 1307535
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA, Mbuagbaw J, Burge SM.
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
    Bezerra EL, Vilar MJ, da Trindade Neto PB, Sato EI.
    Arthritis Rheum; 2005 Oct; 52(10):3073-8. PubMed ID: 16200586
    [Abstract] [Full Text] [Related]

  • 4. Urticarial vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia.
    Nishijima C, Hatta N, Inaoki M, Sakai H, Takehara K.
    Eur J Dermatol; 1999 Oct; 9(1):54-6. PubMed ID: 9920991
    [Abstract] [Full Text] [Related]

  • 5. Bullous systemic lupus erythematosus responding to dapsone.
    Ludgate MW, Greig DE.
    Australas J Dermatol; 2008 May; 49(2):91-3. PubMed ID: 18412808
    [Abstract] [Full Text] [Related]

  • 6. [Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schönlein vasculitis].
    Mazille N, Lipsker D, Fischbach M.
    Arch Pediatr; 2011 Nov; 18(11):1201-4. PubMed ID: 21963373
    [Abstract] [Full Text] [Related]

  • 7. [The treatment of cutaneous loxoscelism with dapsone].
    Benavides MI, Moncada X.
    Rev Med Chil; 1990 Nov; 118(11):1247-50. PubMed ID: 2152651
    [Abstract] [Full Text] [Related]

  • 8. [Disulone: focus on its indications in dermatology].
    Joubert B, Devant O, Amblard P.
    Ann Dermatol Venereol; 1990 Nov; 117(1):63-71. PubMed ID: 2181908
    [No Abstract] [Full Text] [Related]

  • 9. [Dermatologic manifestations in lupus erythematosus].
    Francès C, Barète S, Piette JC.
    Rev Med Interne; 2008 Sep; 29(9):701-9. PubMed ID: 18562046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bullous systemic lupus erythematosus with antiphospholipid syndrome.
    Kacalak-Rzepka A, Zaluga E, Maleszka R, Królicki A, Klimowicz A.
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):490-4. PubMed ID: 15196171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
    Reefman E, de Jong MC, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CG, Bijl M.
    Arthritis Res Ther; 2006 Jul; 8(6):R156. PubMed ID: 17014704
    [Abstract] [Full Text] [Related]

  • 17. Management of skin disease in patients with lupus erythematosus.
    Callen JP.
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):245-64. PubMed ID: 12041952
    [Abstract] [Full Text] [Related]

  • 18. Lupus erythematosus: uncommon presentations.
    Wollina U, Hein G.
    Clin Dermatol; 2005 Apr; 23(5):470-9. PubMed ID: 16179181
    [Abstract] [Full Text] [Related]

  • 19. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
    Highet AS.
    Br J Dermatol; 1980 Mar; 102(3):358-60. PubMed ID: 7370185
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.